Shijiazhuang Yiling Pharmaceutical announced plans to invest 138 million RMB ($22 million) into collaborations with other China pharmas to develop innovative drugs. Last summer, Yiling conducted a very popular IPO on the ChiNext exchange. Because of high investor demand, Yiling raised the price of its shares by one-third, ultimately raising $348 million. The company is now investing some of the “unexpected” proceeds into innovation. More details.... Stock Symbol: (SHE: 002603) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});